论文部分内容阅读
国药“喘立克Ⅰ号”问世北京国际红十字会中医药研究总院是担任气管炎、哮喘病研究与攻关的权威性科研机构,汇集了中外多位著名科研专家,多年来致力于呼吸道疾病最佳特效药的研发,在破译人类气管炎、哮喘病的研究上又获得重大突破,专家们采用呼吸生物学、免疫学的健康理论疗法,融入冬虫夏草、蛤蚧、人参、黄芪、葛根、浮海石等百余种高原名贵中草药进行组合试验,利用国外高科技低温萃取技术,终于成功研制出治疗气管炎、哮喘病的斯一代绿色国药“喘立克Ⅰ号”。该药能迅速修复受损呼吸道黏膜细胞,促进肺部正常功能细胞再生,恢复
Sinopharm “Chuan Like I” Advent Beijing International Red Cross Society of Chinese Medicine Research Institute as a bronchitis, asthma research and research authority of the authority, bringing together a number of well-known Chinese and foreign scientific experts, over the years committed to In the research of deciphering human bronchitis and asthma, we have made great breakthroughs in the research and development of the best effective drugs for respiratory diseases. The experts used respiratory biology and immunotherapy theory of therapies to integrate them into Cordyceps sinensis, Gekko gecko, Ginseng, Radix Astragali, Radix Puerariae, Floating sea stones more than 100 kinds of plateau valuable Chinese herbal medicine combination test, the use of foreign high-tech low-temperature extraction technology, and finally successfully developed the treatment of bronchitis, asthma, the generation of the Green State Drugs The drug can quickly repair damaged respiratory mucosal cells, promote normal lung regeneration of cells, recovery